Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma
Catherine Lee(Sanford Burnham Prebys Medical Discovery Institute), Robert J. Wechsler‐Reya(Columbia University Irving Medical Center), Serap Erkek(Izmir University), Lianne Q. Chau(Sanford Burnham Prebys Medical Discovery Institute), Stefan M. Pfister(Heidelberg University), Paul A. Northcott(St. Jude Children's Research Hospital), Alexandra Garancher(Sanford Burnham Prebys Medical Discovery Institute), H. Leighton Grimes(Cincinnati Children's Hospital Medical Center), Jessica M. Rusert(Sanford Burnham Prebys Medical Discovery Institute), Marc Zapatka(German Cancer Research Center), Vasilisa A. Rudneva(St. Jude Children's Research Hospital), William A. Weiss(City College of San Francisco), Jianxun Wang(University of Notre Dame), Ozlem Aksoy(University of California, San Francisco), Silvia K. Tacheva-Grigorova(Sanford Burnham Prebys Medical Discovery Institute), Helai P. Mohammad(Arysta LifeScience (France)), Robin Lea(University of California, San Francisco)
Cited by 84
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k